Male
Johannes Fruehauf is the President and Co-Founder of Volnay Therapeutics. He previously worked at Sentien Biotechnologies, Inc. as a Board Director. Johannes Fruehauf attended Harvard Medical School.
Headlines from Google News. Social posts load from the platform only when you open a tab.
Failory · Dec 19
Venture Capital Journal · Nov 18
GlobeNewswire · Oct 28
PR Newswire · Sep 4
The Boston Globe · Jul 15